188 related articles for article (PubMed ID: 36639817)
1. Vitamin C boosts DNA demethylation in TET2 germline mutation carriers.
Taira A; Palin K; Kuosmanen A; Välimäki N; Kuittinen O; Kuismin O; Kaasinen E; Rajamäki K; Aaltonen LA
Clin Epigenetics; 2023 Jan; 15(1):7. PubMed ID: 36639817
[TBL] [Abstract][Full Text] [Related]
2. Tet2-mediated DNA demethylation regulates the proliferation and apoptosis of human leukemia K562 cells.
Qiao Y; Zhou Y; Yang H; He Z; Fan A
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):23-27. PubMed ID: 37300692
[TBL] [Abstract][Full Text] [Related]
3. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy.
López-Nevado M; Ortiz-Martín J; Serrano C; Pérez-Saez MA; López-Lorenzo JL; Gil-Etayo FJ; Rodríguez-Frías E; Cabrera-Marante O; Morales-Pérez P; Rodríguez-Pinilla MS; Manso R; Salgado-Sánchez RN; Cerdá-Montagud A; Quesada-Espinosa JF; Gómez-Rodríguez MJ; Paz-Artal E; Muñoz-Calleja C; Arranz-Sáez R; Allende LM
J Clin Immunol; 2023 Jan; 43(1):165-180. PubMed ID: 36066697
[TBL] [Abstract][Full Text] [Related]
4. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
[TBL] [Abstract][Full Text] [Related]
5. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
6. Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans.
Kaasinen E; Kuismin O; Rajamäki K; Ristolainen H; Aavikko M; Kondelin J; Saarinen S; Berta DG; Katainen R; Hirvonen EAM; Karhu A; Taira A; Tanskanen T; Alkodsi A; Taipale M; Morgunova E; Franssila K; Lehtonen R; Mäkinen M; Aittomäki K; Palotie A; Kurki MI; Pietiläinen O; Hilpert M; Saarentaus E; Niinimäki J; Junttila J; Kaikkonen K; Vahteristo P; Skoda RC; Seppänen MRJ; Eklund KK; Taipale J; Kilpivaara O; Aaltonen LA
Nat Commun; 2019 Mar; 10(1):1252. PubMed ID: 30890702
[TBL] [Abstract][Full Text] [Related]
7. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Asmar F; Punj V; Christensen J; Pedersen MT; Pedersen A; Nielsen AB; Hother C; Ralfkiaer U; Brown P; Ralfkiaer E; Helin K; Grønbæk K
Haematologica; 2013 Dec; 98(12):1912-20. PubMed ID: 23831920
[TBL] [Abstract][Full Text] [Related]
9. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
10. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.
Joshi K; Zhang L; Breslin S J P; Kini AR; Zhang J
J Exp Clin Cancer Res; 2022 Oct; 41(1):294. PubMed ID: 36203205
[TBL] [Abstract][Full Text] [Related]
11. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
[TBL] [Abstract][Full Text] [Related]
12. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
13. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
Qi Q; Wang Q; Liu K; Bian J; Yu Z; Hou J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955629
[TBL] [Abstract][Full Text] [Related]
14. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
15. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis.
Tulstrup M; Soerensen M; Hansen JW; Gillberg L; Needhamsen M; Kaastrup K; Helin K; Christensen K; Weischenfeldt J; Grønbæk K
Nat Commun; 2021 Oct; 12(1):6061. PubMed ID: 34663818
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of TET2 in hematologic malignancies.
Chiba S
Int J Hematol; 2017 Jan; 105(1):17-22. PubMed ID: 27848178
[TBL] [Abstract][Full Text] [Related]
17. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
18. Germline TET2 loss of function causes childhood immunodeficiency and lymphoma.
Stremenova Spegarova J; Lawless D; Mohamad SMB; Engelhardt KR; Doody G; Shrimpton J; Rensing-Ehl A; Ehl S; Rieux-Laucat F; Cargo C; Griffin H; Mikulasova A; Acres M; Morgan NV; Poulter JA; Sheridan EG; Chetcuti P; O'Riordan S; Anwar R; Carter CR; Przyborski S; Windebank K; Cant AJ; Lako M; Bacon CM; Savic S; Hambleton S
Blood; 2020 Aug; 136(9):1055-1066. PubMed ID: 32518946
[TBL] [Abstract][Full Text] [Related]
19. TET2: A cornerstone in normal and malignant hematopoiesis.
Kunimoto H; Nakajima H
Cancer Sci; 2021 Jan; 112(1):31-40. PubMed ID: 33048426
[TBL] [Abstract][Full Text] [Related]
20. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]